Hepatic NeoplasmsPReHeBPNCT02784353
Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy
A study testing Perioperative rehabilitation program and Conventional in people with Hepatic Neoplasms and Biliary Tract Neoplasms, run by Asan Medical Center at 1 site in South Korea.
Trial summary
Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Hepatic Neoplasms, Biliary Tract Neoplasms, Pancreatic Neoplasms
- What is being tested?
- Perioperative rehabilitation program and Conventional
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 158 participants
- Where
- 1 siteSouth Korea
- Study dates
- 4 Oct 2016to 24 May 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- >18 years old or <80 years old
- ECOG 0-2
- resectable HBP malignancies or premalignant lesions which should be required GI resection and anastomosis
- open surgery
- no distant metastasis
- no functional disturbance in bone marrow; WBC at least 3,000/mm3 or absolute neutrophil count at least 1,500/mm3, Platelet count at least 125,000/mm3
Show all 9Show fewer
- no functional disturbance in liver; AST less than 5 times upper limit of normal
- no function disturbance in kidney; Creatinine no greater than 1.5 times upper limit of normal
- informed consent
Who cannot join
- distant metastasis (+) or recurred HBP tumor
- active or uncontrolled infection
- alcohol or other drug addiction
- already enrolled patient in other study which affect this study
- pregnant or the possibility of pregnancy (+)
- uncontrolled cardiopulmonary disease
Show all 9Show fewer
- moderate to severe comorbidity which affect on the quality of life and nutritional status (liver cirrhosis, end stage renal disease, heart failure, etc.)
- previous history of major gastrointestinal surgery (gastrectomy, colectomy, etc.)
- previous history of neurological or musculoskeletal diseases which is impossible to allow investigator's order
Trial locations and contacts
1 site in 1 country.
South Korea1 site
Asan Medical Center, University of Ulsan College of Medicine
Seoul, 05505
About this study
Official title: Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP(Hepatobiliary and Pancreatic) Malignancy
Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy.
Read the detailed description
The most important outcome in the management of HBP malignancies is survival. Since the application of ERAS (enhanced recovery after surgery), the improvement of QOL(quality of life) has been known as one of important factor for the management of HBP malignancies as well as survival, and the improvement of QOL, itself, affect the survival.
There are several reports that perioperative rehabilitation affect positively for the outcome of surgery and QOL in surgical patients. However, in the HBP field, there are rarely studied for this concept.
This study aim to investigate that the application of rehabilitation program for the surgery of HBP malignancies affect on short-term outcome and lead the improvement of QOL.
- Being tested
- Perioperative rehabilitation program, Conventional
- Keywords
- Rehabilitation, Quality of life, Surgery, Hepatic neoplasms, Biliary tract neoplasms, Pancreatic neoplasms
- Medical subject headings
- Liver Neoplasms, Biliary Tract Neoplasms, Pancreatic Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Perioperative rehabilitation programBehavioural
Also called PReHeBP
Perioperative rehabilitation program
- preoperative rehabilitation : 2 weeks prior to operation
- postoperative rehabilitation : 3 months after operation
ConventionalBehavioural
Also called No intervention
conventional perioperative management without rehabilitation program
| Study group | Role | What they receive |
|---|---|---|
| Conventional | Active comparator | No intervention; conventional perioperative management without perioperative rehabilitation program Receives: Behavioral: Conventional |
| Intervention - PReHeBP | Experimental | conventional perioperative management with preoperative and postoperative rehabilitation program Receives: Behavioral: Perioperative rehabilitation program |
What is being measured
The primary outcome is the main question the study is designed to answer.
The incidence and severity of general complication
Incidence rate and severity of general complications except operation-specific complication, according to Clavien-Dindo classification
Measured: till postoperative 3 months
Secondary outcomes (7)
The incidence of operation-specific complication
Incidence rate and severity of operation-specific complication, according to Clavien-Dindo classification
Measured: till postoperative 3 months
The incidende of Mortality
Rate of in-hospital mortality and 90 days mortality
Measured: till postoperative 3 months
Rate of re-admission
the rate of re-admission, till postoperative 3 months
Measured: till postoperative 3 months
The changes in Quality of life
changes in quality of life (EORTC QLQ-C30), at the time of discharge and 3 months after surgery
Measured: Comparison between at the time of discharge and postoperative 3months
Compliance of Aerobic exercise, strength exercise and respiratory excursion (Changes in the parameters of rehabilitation)
Compliance of Aerobic exercise, strength exercise and respiratory excursion based on exercise diary
Measured: Initial(2 weeks before surgery), preoperative (within 2days prior to surgery) and 3 months after surgery
Measurement on 6 minutes walk test (m/minute) (Changes in the parameters of rehabilitation)
Measure the 6 minutes walk test (m/minute)
Measured: Initial(2 weeks before surgery), preoperative (within 2days prior to surgery) and 3 months after surgery
Grasping power(dynamometer, kg)(Changes in the parameters of rehabilitation)
Grasping power measurement using dynamometer
Measured: Initial(2 weeks before surgery), preoperative (within 2days prior to surgery) and 3 months after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 May 2016 (estimated)
- Study start4 Oct 2016
- Primary completion24 May 2021
- Study completion24 May 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (11)Papers the sponsor has linked to this study.
- Other trials for Hepatic NeoplasmsStudies of the same condition, open and under way.
- More trials run by Asan Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- 2 arm, parallel, randomized controlled study
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 158 participants (actual)
Sponsor and investigators
- Lead sponsor
- Asan Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Dae Wook Hwang, Asan Medical Center
- Investigators
- DAE WOOK HWANG, M.D., Principal investigator, Asan Medical Center, University of Ulsan College of Medicine, SEOUL, KOREA
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02784353
- Sponsor's protocol ID
- PReHeBP
- Other IDs
- 2015-665
- Acronym
- PReHeBP
- Status last verified
- Nov 2022
- First submitted
- 6 May 2016
- Last updated
- 17 Nov 2022
- Results posted
- No
- Data monitoring committee
- Yes
- Individual data sharing
- No
Publications
Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med. 1970;2(2):92-8. No abstract available.
PubMed 5523831Ford-Smith CD, Wyman JF, Elswick RK Jr, Fernandez T. Reliability of stationary dynamometer muscle strength testing in community-dwelling older adults. Arch Phys Med Rehabil. 2001 Aug;82(8):1128-32. doi: 10.1053/apmr.2001.24291.
PubMed 11494194Johansson K, Tibe K, Weibull A, Newton RC. Low intensity resistance exercise for breast cancer patients with arm lymphedema with or without compression sleeve. Lymphology. 2005 Dec;38(4):167-80.
PubMed 16515225Otsuji H, Yokoyama Y, Ebata T, Igami T, Sugawara G, Mizuno T, Nagino M. Preoperative sarcopenia negatively impacts postoperative outcomes following major hepatectomy with extrahepatic bile duct resection. World J Surg. 2015 Jun;39(6):1494-500. doi: 10.1007/s00268-015-2988-6.
PubMed 25651963Schwartz AL. Fatigue mediates the effects of exercise on quality of life. Qual Life Res. 1999 Sep;8(6):529-38. doi: 10.1023/a:1008978611274.
PubMed 10548868Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, Brach J, Chandler J, Cawthon P, Connor EB, Nevitt M, Visser M, Kritchevsky S, Badinelli S, Harris T, Newman AB, Cauley J, Ferrucci L, Guralnik J. Gait speed and survival in older adults. JAMA. 2011 Jan 5;305(1):50-8. doi: 10.1001/jama.2010.1923.
PubMed 21205966Yeo TP, Burrell SA, Sauter PK, Kennedy EP, Lavu H, Leiby BE, Yeo CJ. A progressive postresection walking program significantly improves fatigue and health-related quality of life in pancreas and periampullary cancer patients. J Am Coll Surg. 2012 Apr;214(4):463-75; discussion 475-7. doi: 10.1016/j.jamcollsurg.2011.12.017. Epub 2012 Feb 7.
PubMed 22321518Yun YH, Park YS, Lee ES, Bang SM, Heo DS, Park SY, You CH, West K. Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res. 2004 May;13(4):863-8. doi: 10.1023/B:QURE.0000021692.81214.70.
PubMed 15129896Shumway-Cook A, Brauer S, Woollacott M. Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go Test. Phys Ther. 2000 Sep;80(9):896-903.
PubMed 10960937Bobbio A, Chetta A, Ampollini L, Primomo GL, Internullo E, Carbognani P, Rusca M, Olivieri D. Preoperative pulmonary rehabilitation in patients undergoing lung resection for non-small cell lung cancer. Eur J Cardiothorac Surg. 2008 Jan;33(1):95-8. doi: 10.1016/j.ejcts.2007.10.003. Epub 2007 Nov 19.
PubMed 18006327Wittes J, Brittain E. The role of internal pilot studies in increasing the efficiency of clinical trials. Stat Med. 1990 Jan-Feb;9(1-2):65-71; discussion 71-2. doi: 10.1002/sim.4780090113.
PubMed 2345839
Study at a glance
From the registry record, last updated by the sponsor on 17 Nov 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP(Hepatobiliary and Pancreatic) Malignancy
- ClinicalTrials.gov ID
- NCT02784353
- Acronym / sponsor ID
- PReHeBP / PReHeBP
- Keywords
- Rehabilitation, Quality of life, Surgery, Hepatic neoplasms, Biliary tract neoplasms, Pancreatic neoplasms
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 158 participants (actual)
- Lead sponsor
- Asan Medical CenterUniversity, hospital or other
- Study start
- 4 Oct 2016 (actual)
- Primary completion
- 24 May 2021 (actual)
- Study completion
- 24 May 2021 (actual)
- First posted
- 27 May 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy.
Detailed description
The most important outcome in the management of HBP malignancies is survival. Since the application of ERAS (enhanced recovery after surgery), the improvement of QOL(quality of life) has been known as one of important factor for the management of HBP malignancies as well as survival, and the improvement of QOL, itself, affect the survival.
There are several reports that perioperative rehabilitation affect positively for the outcome of surgery and QOL in surgical patients. However, in the HBP field, there are rarely studied for this concept.
This study aim to investigate that the application of rehabilitation program for the surgery of HBP malignancies affect on short-term outcome and lead the improvement of QOL.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- 2 arm, parallel, randomized controlled study
| Arm | Type | Receives |
|---|---|---|
| Conventional | Active comparator | Behavioral: ConventionalNo intervention; conventional perioperative management without perioperative rehabilitation program |
| Intervention - PReHeBP | Experimental | Behavioral: Perioperative rehabilitation programconventional perioperative management with preoperative and postoperative rehabilitation program |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (9 listed)
- >18 years old or <80 years old
- ECOG 0-2
- resectable HBP malignancies or premalignant lesions which should be required GI resection and anastomosis
- open surgery
- no distant metastasis
Key exclusion criteria (9 listed)
- distant metastasis (+) or recurred HBP tumor
- active or uncontrolled infection
- alcohol or other drug addiction
- already enrolled patient in other study which affect this study
- pregnant or the possibility of pregnancy (+)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Perioperative rehabilitation programAlso: PReHeBPPerioperative rehabilitation program * preoperative rehabilitation : 2 weeks prior to operation * postoperative rehabilitation : 3 months after operation | Behavioural | Intervention - PReHeBP |
| ConventionalAlso: No interventionconventional perioperative management without rehabilitation program | Behavioural | Conventional |
Primary outcome
The incidence and severity of general complication
Time frame: till postoperative 3 months
Incidence rate and severity of general complications except operation-specific complication, according to Clavien-Dindo classification
7 secondary outcomes
The incidence of operation-specific complication
Time frame: till postoperative 3 months
The incidende of Mortality
Time frame: till postoperative 3 months
Rate of re-admission
Time frame: till postoperative 3 months
The changes in Quality of life
Time frame: Comparison between at the time of discharge and postoperative 3months
Compliance of Aerobic exercise, strength exercise and respiratory excursion (Changes in the parameters of rehabilitation)
Time frame: Initial(2 weeks before surgery), preoperative (within 2days prior to surgery) and 3 months after surgery
Measurement on 6 minutes walk test (m/minute) (Changes in the parameters of rehabilitation)
Time frame: Initial(2 weeks before surgery), preoperative (within 2days prior to surgery) and 3 months after surgery
Grasping power(dynamometer, kg)(Changes in the parameters of rehabilitation)
Time frame: Initial(2 weeks before surgery), preoperative (within 2days prior to surgery) and 3 months after surgery
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Nov 2022.
- Results publication: PubMed 5523831Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med. 1970;2(2):92-8. No abstract available.
- Results publication: PubMed 11494194Ford-Smith CD, Wyman JF, Elswick RK Jr, Fernandez T. Reliability of stationary dynamometer muscle strength testing in community-dwelling older adults. Arch Phys Med Rehabil. 2001 Aug;82(8):1128-32. doi: 10.1053/apmr.2001.24291.
- Results publication: PubMed 16515225Johansson K, Tibe K, Weibull A, Newton RC. Low intensity resistance exercise for breast cancer patients with arm lymphedema with or without compression sleeve. Lymphology. 2005 Dec;38(4):167-80.
- Results publication: PubMed 25651963Otsuji H, Yokoyama Y, Ebata T, Igami T, Sugawara G, Mizuno T, Nagino M. Preoperative sarcopenia negatively impacts postoperative outcomes following major hepatectomy with extrahepatic bile duct resection. World J Surg. 2015 Jun;39(6):1494-500. doi: 10.1007/s00268-015-2988-6.
- Results publication: PubMed 10548868Schwartz AL. Fatigue mediates the effects of exercise on quality of life. Qual Life Res. 1999 Sep;8(6):529-38. doi: 10.1023/a:1008978611274.
- Results publication: PubMed 21205966Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, Brach J, Chandler J, Cawthon P, Connor EB, Nevitt M, Visser M, Kritchevsky S, Badinelli S, Harris T, Newman AB, Cauley J, Ferrucci L, Guralnik J. Gait speed and survival in older adults. JAMA. 2011 Jan 5;305(1):50-8. doi: 10.1001/jama.2010.1923.
- Results publication: PubMed 22321518Yeo TP, Burrell SA, Sauter PK, Kennedy EP, Lavu H, Leiby BE, Yeo CJ. A progressive postresection walking program significantly improves fatigue and health-related quality of life in pancreas and periampullary cancer patients. J Am Coll Surg. 2012 Apr;214(4):463-75; discussion 475-7. doi: 10.1016/j.jamcollsurg.2011.12.017. Epub 2012 Feb 7.
- Results publication: PubMed 15129896Yun YH, Park YS, Lee ES, Bang SM, Heo DS, Park SY, You CH, West K. Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res. 2004 May;13(4):863-8. doi: 10.1023/B:QURE.0000021692.81214.70.
- Results publication: PubMed 10960937Shumway-Cook A, Brauer S, Woollacott M. Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go Test. Phys Ther. 2000 Sep;80(9):896-903.
- Results publication: PubMed 18006327Bobbio A, Chetta A, Ampollini L, Primomo GL, Internullo E, Carbognani P, Rusca M, Olivieri D. Preoperative pulmonary rehabilitation in patients undergoing lung resection for non-small cell lung cancer. Eur J Cardiothorac Surg. 2008 Jan;33(1):95-8. doi: 10.1016/j.ejcts.2007.10.003. Epub 2007 Nov 19.
- Results publication: PubMed 2345839Wittes J, Brittain E. The role of internal pilot studies in increasing the efficiency of clinical trials. Stat Med. 1990 Jan-Feb;9(1-2):65-71; discussion 71-2. doi: 10.1002/sim.4780090113.
- Individual participant dataSharing planned: No
Related trials for Hepatic Neoplasms
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis
HCC
RecruitingObservational study
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Liver Neoplasms, Primary Liver Cancer
Not yet recruitingPhase 1
A Study to Assess the Pharmacokinetics and Safety of Revumenib in Participants With Advanced Cancer and Hepatic or Renal Impairment
Relapsed/Refractory (R/R) Hematologic Malignancies, Acute Leukemia
Recruiting
The Vanguard Study: Testing a New Way to Screen for Cancer
Bladder Carcinoma, Breast Carcinoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
DAE WOOK HWANG, M.D. principal investigator
Asan Medical Center, University of Ulsan College of Medicine, SEOUL, KOREA
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Perioperative rehabilitation program and Conventional in people with Hepatic Neoplasms and Biliary Tract Neoplasms, run by Asan Medical Center at 1 site in South Korea.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 17 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The incidence and severity of general complication (time frame: till postoperative 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02784353, which also lists 11 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Nov 2022.